TheProfitWatch

SAVA - Cassava Sciences, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.46 0.17 (3.79%) 0.0 (0.0%) 0.0 (0.0%) 0.07 (1.5%) 0.03 (0.67%) 0.15 (3.33%) -0.02 (-0.45%) -0.02 (-0.45%)

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.92
Diluted EPS:
-0.92
Basic P/E:
-5.0317
Diluted P/E:
-5.0317
RSI(14) 1m:
0.0
VWAP:
4.63
RVol:

Events

Period Kind Movement Occurred At

Related News